The program on Five Live focuses on obesity, a major health concern in India, where approximately 40.3% of adults are clinically obese. The discussion highlights the limitations of Body Mass Index (BMI) as a sole parameter for defining fatness, suggesting alternative methods like waist-to-hip ratio and body fat percentage. It also differentiates between visible fat and visceral fat, emphasizing the dangers of the latter. The segment explores the emergence of anti-obesity drugs, including GLP-1, Banjaro, and Vigovi, as a significant pharmaceutical advancement. A critical point raised is the challenge of ensuring these drugs are used appropriately. It is stated that "The key here is that this is not a drug that can be self-prescribed. The key here is you need to know when to start, how much to have and importantly when to stop." The program stresses the importance of consulting specialists like endocrinologists for informed decisions regarding weight loss medication. #obesity #health #weightlossdrugs #itwebvideos #antiobesitydrugs #glp1 #bmi #visceralfat #skinnyfat #diabetes #heartdisease #kidneydisease #endocrinologist #medicaltreatment #healthfocus #indiahealth #publichealth #drugrevolution #healthdebate
Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you’ll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!
India Today TV is India’s leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.
Stay tuned for latest updates and in-depth analysis of news from India and around the world!
WhatsApp Channel: https://whatsapp.com/channel/0029Va2AnW3JENxxg7OuJv00
Download App: https://indiatoday.link/wHaj
Follow us: Official website: https://www.indiatoday.in/
Twitter: https://twitter.com/IndiaToday
Facebook: https://www.facebook.com/IndiaToday
